Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
DISA ( (SG:532) ) just unveiled an update.
Digital Life Line Pte. Ltd., a subsidiary of DISA Limited, has secured a contract for the clinical deployment of its Automated Visual Acuity Test (AVAT) devices at a hospital ophthalmology clinic in Singapore, marking a significant milestone in the digitalization of eye care. This deployment, backed by a CE mark for compliance with EU regulations, follows a successful pilot study and introduces a new revenue model with a fixed monthly rental and per-test fee, highlighting the growing impact of AI-enabled medical devices in the healthcare industry.
More about DISA
DISA Limited, incorporated in Singapore, operates through its subsidiaries in the digital and safety sectors. The company focuses on technological innovations, particularly in the healthcare industry through its subsidiary Digital Life Line Pte. Ltd., which develops and commercializes medical devices such as automated visual acuity test systems.
Current Market Cap: S$10.51M
For detailed information about 532 stock, go to TipRanks’ Stock Analysis page.
